Comparison of Emdogain with T-PRF and RhBMP-2 with T-PRF gingival recession treatment.

Comparative evaluation of Emdogain with T-PRF and Rh BMP-2 with T-PRF in treatment of Gingival recession. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077961

Enrollment

Registered

2024-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K060- Gingival recession

Interventions

Intervention1: Emdogain: Emdogain gel containing enamel matrix derivative (EMD) 0.15ml along with titanium prepared platelet rich fibrin (t prf)(centrifuged at 2800rpm for 12 minutes) is placed with c

Eligibility

Inclusion criteria

Inclusion criteria: Patients with age range 20 to 50 years. Patients showing a tendency to maintain good oral hygiene. Patients without any other periodontal diseases. Patients with good systemic health.

Exclusion criteria

Exclusion criteria: Patients with systemic diseases Inability or unwillingness to complete the trial. Patients on any medication that could affect or alter the course of periodontal treatment. Poor oral hygiene. Pregnant, Lactating mothers. History of smoking and alcohol abuse.

Design outcomes

Primary

Measure	Time frame
Keratinized tissue width measurement Clinical attachment level measurementTimepoint: Keratinized tissue width measurement at baseline and 9 months Clinical attachment level measurement at baseline and 9 months	—

Secondary

Measure	Time frame
Probing depth measurementTimepoint: Probing depth measurement at baseline & 9 months	—

Countries

India

Contacts

Public ContactMANDALAPU NARENDRA BABU

St. Joseph Dental College

sjdcperiodontics@gmail.com9000095678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026